Dendritic Cell Vaccine and Cancer Treatment: New Patents

ISSN: 2212-3334 (Online)
ISSN: 1872-2148 (Print)

Volume 9, 2 Issues, 2015

Download PDF Flyer

Recent Patents on Endocrine Metabolic & Immune Drug Discovery

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Dendritic Cell Vaccine and Cancer Treatment: New Patents

Author(s): Andre A.R. Aleixo, Marcia A. Michelin and Eddie F.C. Murta

Affiliation: Oncology Research Institute (IPON), Discipline of Gynecology and Obstetrics, (UFTM), Avenida Getulio Guarita, sn, Uberaba (MG), CEP 38025-440, Bairro Abadia, Brazil.


Dendritic cell (DC) immunotherapy has been used to treat various types of tumors. Although it is already in use in clinical practice, the mechanisms through which it acts need clarification. In addition, the processes used to obtain DCs need to be improved so that more effective treatments can be offered. In this article, we present an update on the application of DC immunotherapy and the patents involved in the process.

Keywords: Cancer, dendritic cells, immunotherapy, neoplasia, new aspects, patents in immunotherapy, tumor.

Download Free Order Reprints Order Eprints Rights and Permissions


Article Details

Volume: 8
Issue Number: 1
First Page: 26
Last Page: 29
Page Count: 4
DOI: 10.2174/1872214807666140107152008

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science